The results of OS analysis suggested that GPC-1 was a perilous factor for patients with LGG, UVM, LIHC, BLCA, LUAD, MESO, COAD, THCA, ACC, OV, and SKCM, while a protective factor for patients with LGG, UVM, HCC, BLCA (Figure S1). Here, GPC1 is linked to bladder transitional cell carcinoma.